Literature DB >> 7812516

A surface replica method: a useful tool for studies of the cytoskeletal network in red cell membranes of normal subjects and patients with a beta-spectrin mutant (spectrin Le Puy: beta 220/214).

A Yawata1, A Kanzaki, K Uehira, Y Yawata.   

Abstract

Visualization of the components of the red cell membranes, and especially the structure of cytoskeletal proteins in situ, has become a requisite in studies of red cell membrane disorders. There has been a search for a consistent and dependable method for detecting these structures. In the present study, the surface replica method was used with transmission electron microscopy to examine the cytoskeletal network of the red cell ghosts of a normal control and patients with a beta-spectrin mutant (beta-spectrin Le Puy). The surface replica method is well-suited to observation of the cytoskeletal network of the membranes in a nearly native in situ condition. Immunogold labelling with anti-membrane protein antibodies is easily applicable to the identification of each component of the cytoskeletal proteins. The findings obtained under normal and pathological conditions using the surface replica method corresponded with those made by the quick-freeze, deep-etching method.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7812516     DOI: 10.1007/bf00196153

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  41 in total

1.  Spectrin Rouen (beta 220-218), a novel shortened beta-chain variant in a kindred with hereditary elliptocytosis. Characterization of the molecular defect as exon skipping due to a splice site mutation.

Authors:  M Garbarz; W T Tse; P G Gallagher; C Picat; M C Lecomte; F Galibert; D Dhermy; B G Forget
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

2.  Ultrastructure of the human erythrocyte cytoskeleton and its attachment to the membrane.

Authors:  J A Ursitti; D W Pumplin; J B Wade; R J Bloch
Journal:  Cell Motil Cytoskeleton       Date:  1991

3.  Immunocytochemical study of membrane skeletons in abnormally shaped erythrocytes as revealed by a quick-freezing and deep-etching method.

Authors:  S Ohno; N Terada; Y Fujii; H Ueda; H Kuramoto; N Kamisawa
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

4.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  Band 4.2 abnormalities in human red cells.

Authors:  Y Yawata
Journal:  Am J Med Sci       Date:  1994-03       Impact factor: 2.378

7.  Ultrastructure and immunocytochemistry of the isolated human erythrocyte membrane skeleton.

Authors:  J A Ursitti; J B Wade
Journal:  Cell Motil Cytoskeleton       Date:  1993

8.  Oligomeric states of spectrin in normal erythrocyte membranes: biochemical and electron microscopic studies.

Authors:  S C Liu; P Windisch; S Kim; J Palek
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

9.  Point mutation in the beta-spectrin gene associated with alpha I/74 hereditary elliptocytosis. Implications for the mechanism of spectrin dimer self-association.

Authors:  W T Tse; M C Lecomte; F F Costa; M Garbarz; C Feo; P Boivin; D Dhermy; B G Forget
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

10.  Cytoskeletal network underlying the human erythrocyte membrane. Thin-section electron microscopy.

Authors:  S Tsukita; S Tsukita; H Ishikawa
Journal:  J Cell Biol       Date:  1980-06       Impact factor: 10.539

View more
  1 in total

1.  Defective anion transport and marked spherocytosis with membrane instability caused by hereditary total deficiency of red cell band 3 in cattle due to a nonsense mutation.

Authors:  M Inaba; A Yawata; I Koshino; K Sato; M Takeuchi; Y Takakuwa; S Manno; Y Yawata; A Kanzaki; J Sakai; A Ban; K Ono; Y Maede
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.